AARP Georgia State Director, Debra Tyler-Horton, released the following statement today, applauding Reps. Sanford Bishop, Hank Johnson, John Lewis, Lucy McBath, and David Scott, of the U.S. House of Representatives for voting to pass H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act.
WASHINGTON—Retail prices for 267 brand-name drugs commonly used by older adults surged by an average of 5.8% in 2018, more than twice the general inflation rate of 2.4%, according to new AARP Public Policy Institute (PPI) data released today. The annual average cost of therapy for one brand-name drug ballooned to more than $7,200 in 2018, up from nearly $1,900 in 2006.